Analysis of the cellular mechanism of antitumor responses and autoimmunity in patients treated with CTLA-4 blockade

被引:252
作者
Maker, AV [1 ]
Attia, P [1 ]
Rosenberg, SA [1 ]
机构
[1] NCI, Surg Branch, NIH, Bethesda, MD 20814 USA
关键词
D O I
10.4049/jimmunol.175.11.7746
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have demonstrated previously that the administration of CTLA-4 blockade has mediated objective cancer regression and autoimmunity in patients with metastatic melanoma. To explore the mechanism of these in vivo effects, we have studied the changes in lymphocyte phenotype and function in patients receiving anti-CTLA-4 Ab (MDX-010). Patients with stage IV melanoma or renal cell cancer were treated every 3 wk with an anti-CTLA-4 Ab with or without peptide immunization. Pheresis samples were analyzed using flow cytometry to determine lymphocyte cell surface markers. Gene expression analyses and proliferation assays were conducted on purified T cell subsets. Anti-CTLA-4 Ab did not inhibit the suppressive activity of CD4(+)CD25(+) cells in vitro or in vivo. In addition, there was no decrease in the expression of CD4(+)CD25(+) cells in whole PBMC, nor a decrease in Foxp3 gene expression in the CD4(+) or CD4(+)CD25(+) purified cell populations posttreatment. The percentage of CD4(+), CD8(+), CD4(+)CD25(+), and CD4(+)CD25(-) T cells in PBMC expressing the activation marker HLA-DR increased following anti-CTLA-4 Ab administration. Therefore, our results suggest that the antitumor effects of CTLA-4 blockade are due to increased T cell activation rather than inhibition or depletion of T regulatory cells.
引用
收藏
页码:7746 / 7754
页数:9
相关论文
共 47 条
  • [1] T-cell regulation by CD28 and CTLA-4
    Alegre, ML
    Frauwirth, KA
    Thompson, CB
    [J]. NATURE REVIEWS IMMUNOLOGY, 2001, 1 (03) : 220 - 228
  • [2] CD8+T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells
    Antony, PA
    Piccirillo, CA
    Akpinarli, A
    Finkelstein, SE
    Speiss, PJ
    Surman, DR
    Palmer, DC
    Chan, CC
    Klebanoff, CA
    Overwijk, WW
    Rosenberg, SA
    Restifo, NP
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 174 (05) : 2591 - 2601
  • [3] Arvå E, 1999, SCAND J IMMUNOL, V49, P237
  • [4] Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4
    Attia, P
    Phan, GQ
    Maker, AV
    Robinson, MR
    Quezado, MM
    Yang, JC
    Sherry, RM
    Topalian, SL
    Kammula, US
    Royal, RE
    Restifo, NP
    Haworth, LR
    Levy, C
    Mavroukakis, SA
    Nichol, G
    Yellin, MJ
    Rosenberg, SA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) : 6043 - 6053
  • [5] Human CD4+CD25+ regulatory T cells
    Baecher-Allan, C
    Viglietta, V
    Hafler, DA
    [J]. SEMINARS IN IMMUNOLOGY, 2004, 16 (02) : 89 - 97
  • [6] CD4+CD25high regulatory cells in human peripheral blood
    Baecher-Allan, C
    Brown, JA
    Freeman, GJ
    Hafler, DA
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (03) : 1245 - 1253
  • [7] The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3
    Bennett, CL
    Christie, J
    Ramsdell, F
    Brunkow, ME
    Ferguson, PJ
    Whitesell, L
    Kelly, TE
    Saulsbury, FT
    Chance, PF
    Ochs, HD
    [J]. NATURE GENETICS, 2001, 27 (01) : 20 - 21
  • [8] A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAA→AAUGAA) leads to the IPEX syndrome
    Bennett, CL
    Brunkow, ME
    Ramsdell, F
    O'Briant, KC
    Zhu, Q
    Fuleihan, RL
    Shigeoka, AO
    Ochs, HD
    Chance, PF
    [J]. IMMUNOGENETICS, 2001, 53 (06) : 435 - 439
  • [9] Suppressive properties of human CD4+CD25+ regulatory T cells are dependent on CTLA-4 expression
    Birebent, B
    Lorho, R
    Lechartier, H
    de Guibert, S
    Alizadeh, M
    Vu, N
    Beauplet, A
    Robillard, N
    Semana, G
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (12) : 3485 - 3496
  • [10] Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse
    Brunkow, ME
    Jeffery, EW
    Hjerrild, KA
    Paeper, B
    Clark, LB
    Yasayko, SA
    Wilkinson, JE
    Galas, D
    Ziegler, SF
    Ramsdell, F
    [J]. NATURE GENETICS, 2001, 27 (01) : 68 - 73